Lung neoplasms are the leading cause of death by cancer worldwide. Non-small cell lung
cancer (NSCLC) constitutes more than 80% of all lung malignancies and the majority of …

Cytokines are pivotal mediators of the immune response, and their coordinated expression
protects host tissue from excessive damage and oxidant stress. Nevertheless, the …

Non-small cell lung cancer is a prevalent and rapidly-expanding challenge to modern
medicine. While generalized medicine with traditional chemotherapy yielded comparatively …

Abstract Background and Objective The economic assessment of immuno-oncology agents
in Chinese patients is limited despite a need for new therapies. Nivolumab is the first …

CRISPR (clustered regularly interspaced short palindromic repeats) systems are one of the
most fascinating tools of the current era in molecular biotechnology. With the ease that they …

Purpose To assess the cost-effectiveness of osimertinib used as a second-line treatment
after failure of epidermal growth factor receptor tyrosine kinase inhibitor therapy for …

Non-communicable diseases (NCDs) are the leading cause of death and disease burden
globally, cardiovascular diseases (CVDs) account for the major part of death related to …

Introduction To assess the cost-effectiveness of alectinib versus crizotinib as first-line
treatments for advanced anaplastic lymphoma kinase (ALK)-positive non-small cell lung …

Objective To investigate the cost-effectiveness of ramucirumab plus erlotinib compared with
placebo plus erlotinib in the first-line setting for patients with EGFR-mutated metastatic non …

Magnesium may reduce the risk of lung cancer by affecting cell proliferation, inflammation
and by preserving lung function; however, the results of epidemiological studies on the …